Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases

Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891 · see citing works

Cyclodextrin-based pharmaceutics: past, present and future

Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 2,002 · see citing works

International Conference on Harmonisation

Guy, R. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,487 · see citing works

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

Labiris, N. R., & DOLOVICH, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,250 · see citing works

Global Tuberculosis Control 2011, WHO Report 2011

Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022 · see citing works

Nanomedicine(s) under the Microscope

Duncan, R., & Gaspar, R. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 985 · see citing works

Development of Nanoparticles for Antimicrobial Drug Delivery

Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-W. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 890 · see citing works

Formulation strategy and use of excipients in pulmonary drug delivery

Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791 · see citing works

Amphotericin B: side effects and toxicity

Laniado-Laborín, R., & Cabrales-Vargas, M. N. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.06.003 · Cited by 739 · see citing works

Influence of particle size on regional lung deposition – What evidence is there?

Carvalho, T. C., Peters, J. I., & Williams III, R. O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.040 · Cited by 614 · see citing works

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

LIMPER, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 608 · see citing works

Targeting to macrophages: role of physicochemical properties of particulate carriers–liposomes and microspheres – on the phagocytosis by macrophages

Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570 · see citing works

Dry Powder Inhaler Formulation

Telko, M. J., & Hickey, A. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501209 · Cited by 515 · see citing works

Aerosol drug delivery: developments in device design and clinical use

DOLOVICH, M. B., & Dhand, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60926-9 · Cited by 506 · see citing works

Nanomedicine in pulmonary delivery

Mansour, H. M., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 486 · see citing works

Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

Labiris, N. R., & DOLOVICH, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01893.x · Cited by 452 · see citing works

Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications

Pinto‐Alphandary, H., Andremont, A., & Couvreur, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00121-1 · Cited by 428 · see citing works

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 389 · see citing works

Emerging nanopharmaceuticals

Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 342 · see citing works

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318 · see citing works

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

Zahoor, A., Sharma, S., & Khuller, G. K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.07.012 · Cited by 314 · see citing works

Nanoparticle formulations in pulmonary drug delivery

Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302 · see citing works

Global Tuberculosis Control: WHO Report 2011

Williams, C. (2012) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2012.00928.x · Cited by 268 · see citing works

Biodegradable polymeric nanocarriers for pulmonary drug delivery

Rytting, E., Nguyen, J., Wang, X., & Kissel, T. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.629 · Cited by 266 · see citing works

New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery

Sosnik, A., Carcaboso, A. M., Glisoni, R. J., Moretton, M. A., & Chiappetta, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.023 · Cited by 264 · see citing works

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

Vyas, S. P., Kannan, M., Jain, S., Mishra, V. K., & Singh, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262 · see citing works

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

Sharma, A., Sharma, S., & Khuller, G. K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh411 · Cited by 251 · see citing works

Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

Vandamme (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1045 · Cited by 238 · see citing works

Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro

Grenha, A., Grainger, C. I., Dailey, L. A., Seijo, B., Martin, G. P., Remuñán‐López, C., & Forbes, B. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.008 · Cited by 222 · see citing works

Pneumonia in the intensive care unit

Rello, J., & Dı́az, E. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089928.84326.d2 · Cited by 202 · see citing works

Inhalation therapy: an historical review

Sanders, M. (2007) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2007.00017 · Cited by 199 · see citing works

Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells

Fattal, E., Mura, S., Nicolas, J., Hillaireau, H., Gueutin, Droumaguet, B. L., Zanna, S., & Tsapis, N. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24552 · Cited by 192 · see citing works

Antitubercular inhaled therapy: opportunities, progress and challenges

Pandey, R., & Khuller, G. K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki027 · Cited by 188 · see citing works

One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis

Ohashi, K., Kabasawa, T., Ozeki, T., & Okada, H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.11.027 · Cited by 178 · see citing works

The antimicrobial efficacy of sustained release silver–carbene complex-loaded l-tyrosine polyphosphate nanoparticles: Characterization, in vitro and in vivo studies

Hindi, K. M., Ditto, A. J., Panzner, M. J., Medvetz, D. A., Han, D., Hovis, C. E., Hilliard, J. K., Taylor, J. B., Yun, Y., Cannon, C. L., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.044 · Cited by 171 · see citing works

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

Beckham, J. D., Cadena, A., Lin, J., Piedra, P. A., Glezen, W. P., Greenberg, S. B., & Atmar, R. L. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.07.011 · Cited by 168 · see citing works

Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections

Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.011 · Cited by 164 · see citing works

Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection

Omri, A., Suntres, Z. E., & Shek, P. N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01346-1 · Cited by 160 · see citing works

Respirable PLGA Microspheres Containing Rifampicin for the Treatment of Tuberculosis: Screening in An Infectious Disease Model

Suarez, S., O’Hara, P. J., Kazantseva, M., Newcomer, C. E., Hopfer, R. L., McMurray, D. N., & Hickey, A. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094112861 · Cited by 159 · see citing works

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

Suarez, S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.431 · Cited by 156 · see citing works

Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection

Wong, J. P., Yang, H., Blasetti, K. L., Schnell, G., Conley, J., & Schofield, L. N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00358-4 · Cited by 153 · see citing works

International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.

(2010) · PubMed · Cited by 150 · see citing works

FDA's Approach to Regulation of Products of Nanotechnology

Hamburg, M. A. (2012) · Science · doi:10.1126/science.1205441 · Cited by 149 · see citing works

Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains

Alipour, M., Halwani, M., Omri, A., & Suntres, Z. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.035 · Cited by 148 · see citing works

Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology

(2011) · Biotechnology Law Report · doi:10.1089/blr.2011.9814 · Cited by 146 · see citing works

Inhaled Drug Delivery for Tuberculosis Therapy

Muttil, P., Wang, C., & Hickey, A. J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9957-4 · Cited by 145 · see citing works

Inhaled Large Porous Particles of Capreomycin for Treatment of Tuberculosis in a Guinea Pig Model

Garcia‐Contreras, L., Fiegel, J., Telko, M. J., Elbert, K. J., Hawi, A. A., Thomas, M., VerBerkmoes, J. L., Germishuizen, W. A., Fourie, P. B., Hickey, A. J., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-06 · Cited by 139 · see citing works

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

Aitken, M. L. (1992) · JAMA · doi:10.1001/jama.267.14.1947 · Cited by 139 · see citing works

Nanodelivery in airway diseases: Challenges and therapeutic applications

Roy, I., & Vij, N. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.001 · Cited by 137 · see citing works

HYPERGLYCAEMIA AND DIABETES AFTER BURNS.

Piggott, H. (1965) · PubMed · Cited by 137 · see citing works

Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa

Geller, D. E., Flume, P. A., Staab, D., Fischer, R., Loutit, J., & Conrad, D. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1293oc · Cited by 132 · see citing works

Liposomes for drug delivery to the lungs by nebulization

Zaru, M., Mourtas, S., Klepetsanis, P. G., Fadda, A. M., & Antimisiaris, S. G. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.04.005 · Cited by 131 · see citing works

Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing”

Young, P. M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D. F., & Tobyn, M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760345400 · Cited by 130 · see citing works

Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect

Videira, M., Almeida, A. J., & Fabra, À. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.007 · Cited by 128 · see citing works

Chitosan-coated liposomes for delivery to lungs by nebulisation

Zaru, M., Manca, M. L., Fadda, A. M., & Antimisiaris, S. G. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.01.010 · Cited by 120 · see citing works

History of Aerosol Therapy: Liquid Nebulization to MDIs to DPIs

ANDERSON, P. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501139 · Cited by 120 · see citing works

The Failure of Exubera: Are We Beating a Dead Horse?

Heinemann, L. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200325 · Cited by 119 · see citing works

Dry Powder Inhaler Device Influence on Carrier Particle Performance

Donovan, M. J., Kim, S. H., Raman, V., & Smyth, H. D. C. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22824 · Cited by 118 · see citing works

Liposomes as Drug Delivery Systems for The Treatment of TB

Pinheiro, M., Lúcio, M., Lima, J. L. F. C., & Reis, S. (2011) · Nanomedicine · doi:10.2217/nnm.11.122 · Cited by 115 · see citing works

Prevention and Treatment ofStaphylococcus aureusPneumonia with a β-Cyclodextrin Derivative

Ragle, B. E., Karginov, V. A., & Wardenburg, J. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00973-09 · Cited by 113 · see citing works

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery

Sweeney, L. G., Wang, Z., Löebenberg, R., Wong, J. P., Lange, C. F., & Finlay, W. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.010 · Cited by 112 · see citing works

High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers

Yang, W. P., Tam, J. M., Miller, D. A., Zhou, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.003 · Cited by 111 · see citing works

Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation

Changsan, N., Chan, H., Separovic, F., & Srichana, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21441 · Cited by 108 · see citing works

Recombinant Human DNase Inhalation in Normal Subjects and Patients With Cystic Fibrosis

Aitken, M. L. (1992) · JAMA · doi:10.1001/jama.1992.03480140073036 · Cited by 107 · see citing works

New respiratory viral infections

Jartti, T. T., Jartti, L., Ruuskanen, O., & Söderlund‐Venermo, M. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328351f8d4 · Cited by 105 · see citing works

Formulation of rifampicin–cyclodextrin complexes for lung nebulization

Tewes, F., Brillault, J., Couet, W. R., & Olivier, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.007 · Cited by 103 · see citing works

Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis

Hwang, S., Kim, D. D., Chung, S., & Shim, C. K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.009 · Cited by 103 · see citing works

Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages

Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100 · see citing works

Biomedical Detection via Macro- and Nano-Sensors Fabricated with Metallic and Semiconducting Oxides

Hahm, J. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1468 · Cited by 98 · see citing works

Steroid Aerosols in Asthma: An Assessment of Betamethasone Valerate and a 12-month Study of Patients on Maintenance Treatment

McAllen, M. K., Kochanowski, S. J., & Shaw, K. M. (1974) · BMJ · doi:10.1136/bmj.1.5900.171 · Cited by 94 · see citing works

Non-clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals: ICH M3 and M3(R2)

Sjöberg, P. J. R., & Jones, D. R. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-5950-7_14 · Cited by 92 · see citing works

Hydrolyzed Galactomannan-Modified Nanoparticles and Flower-Like Polymeric Micelles for the Active Targeting of Rifampicin to Macrophages

Moretton, M. A., Chiappetta, D. A., Andrade, F., das Neves, J., Ferreira, D., Sarmento, B. F. C. C., & Sosnik, A. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1600 · Cited by 91 · see citing works

Viral respiratory tract infections and asthma: The course ahead

Rosenthal, L. A., Avila, P. C., Heymann, P. W., Martin, R. J., Miller, E. K., Papadopoulos, N. G., Peebles, R. S., & Gern, J. E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.002 · Cited by 89 · see citing works

Single dose and multiple dose studies of itraconazole nanoparticles

Vaughn, J. M., McConville, J. T., Burgess, D., Peters, J. I., Johnston, K. P., Talbert, R. L., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.006 · Cited by 85 · see citing works

Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice

Agarwal, A., Kandpal, H., Gupta, H. P., Singh, N. B., & Gupta, C. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.588 · Cited by 81 · see citing works

Enhanced killing of methicillin-resistantStaphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin

Onyeji, C. O., Nightingale, C. H., & Marangos, M. N. (1994) · Infection · doi:10.1007/bf01715542 · Cited by 79 · see citing works

Preparation and use of Liposomes in the Treatment of Microbial Infections

Swenson, C. E., Popescu, M. C., Ginsberg, R. S., & Juliano, R. L. (1988) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418809104463 · Cited by 78 · see citing works

Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation

Justo, O. R., & Moraes, Â. M. (2003) · Drug Delivery · doi:10.1080/713840401 · Cited by 77 · see citing works

Nanocarriers for Pulmonary Administration of Peptides and Therapeutic Proteins

Andrade, F., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.143 · Cited by 76 · see citing works

Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages:in vitroandin vivoevaluation

Zaru, M., Sinico, C., Logu, A. D., Caddeo, C., Lai, F., Manca, M. L., & Fadda, A. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100802610835 · Cited by 73 · see citing works

Targeted High Lung Concentrations of Itraconazole Using Nebulized Dispersions in a Murine Model

McConville, J. T., Overhoff, K. A., Sinswat, P., Vaughn, J. M., Frei, B. L., Burgess, D. S., Talbert, R. L., Peters, J. I., Johnston, K. P., & Williams, R. O. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9904-6 · Cited by 65 · see citing works

A History of Nebulization

Dessanges, J. F. (2001) · Journal of Aerosol Medicine · doi:10.1089/08942680152007918 · Cited by 61 · see citing works

Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats

Marier, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg317 · Cited by 60 · see citing works

Rationale for and Efficacy of Prolonged-Interval Treatment Using Liposome-Encapsulated Amikacin in Experimental Mycobacterium avium Infection

Leitzke, S., Bucke, W., Börner, K., Müller, R. H., Hahn, H. H., & Ehlers, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.459 · Cited by 59 · see citing works

Pure Insulin Nanoparticle Agglomerates for Pulmonary Delivery

Bailey, M. M., Gorman, E. M., Munson, E. J., & Berkland, C. J. (2008) · Langmuir · doi:10.1021/la802405p · Cited by 56 · see citing works

Pulmonary Immunization Using Antigen 85-B Polymeric Microparticles to Boost Tuberculosis Immunity

Lu, D., Garcia‐Contreras, L., Muttil, P., Padilla, D., Xu, D., Liu, J., Braunstein, M., McMurray, D. N., & Hickey, A. J. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9193-1 · Cited by 56 · see citing works

Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis.

Vladimirsky, M. A., & Ga, L. (1982) · PubMed · Cited by 56 · see citing works

Interactions of pluronic block copolymers on P‐gp efflux activity: Experience with HIV‐1 protease inhibitors

Shaik, N., Pan, G., & Elmquist, W. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21372 · Cited by 55 · see citing works

Superior Chemotherapeutic Efficacy of Amphotericin B in Tuftsin-bearing Liposomes against Leishmania Donovani Infection in Hamsters

Agrawal, A. K., Agrawal, A., Pal, A. K., Guru, P. Y., & Gupta, C. M. (2002) · Journal of drug targeting · doi:10.1080/10611860290007513 · Cited by 54 · see citing works

Development of Respirable Nanomicelle Carriers for Delivery of Amphotericin B by Jet Nebulization

Gilani, K., Moazeni, E., Ramezanli, T., Amini, M., Fazeli, M. R., & Jamalifar, H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22274 · Cited by 53 · see citing works

Liposome-based drug delivery to alveolar macrophages

Vyas, S. P., & Khatri, K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.95 · Cited by 52 · see citing works

Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment

Justo, O. R., & Moraes, Â. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055092 · Cited by 50 · see citing works

Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes

Gangadharam, P. R., Ashtekar, D. R., Flasher, D., & Düzgüneş, N. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.725 · Cited by 49 · see citing works

Future of Nanomedicine: Obstacles and Remedies

Bosetti, R., & Vereeck, L. (2011) · Nanomedicine · doi:10.2217/nnm.11.55 · Cited by 48 · see citing works

In Vivo Efficacy of Aerosolized Nanostructured ItraconazoleFormulations for Prevention of Invasive Pulmonary Aspergillosis

Hoeben, B. J., Burgess, D. S., McConville, J. T., Najvar, L. K., Talbert, R. L., Peters, J. I., Wiederhold, N. P., Frei, B. L., Graybill, J. R., Bocanegra, R. A., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1552-1554.2006 · Cited by 46 · see citing works

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis

Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.014 · Cited by 43 · see citing works

Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2: an Outcome Study

Huland, E., Burger, A., Fleischer, J., Fornara, P., Hatzmann, E., Heidenreich, A., Heinzer, H., Heynemann, H., Hoffmann, L., Hofmann, R., et al. (2003) · Folia Biologica · doi:10.14712/fb2003049050183 · Cited by 42 · see citing works

The activity of low-clearance liposomal amikacin in experimental murine tuberculosis

Dhillon, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.869 · Cited by 38 · see citing works

Tuftsin‐bearing liposomes as drug vehicles in the treatment of experimental aspergillosis

Owais, M., Ahmed, I., Krishnakumar, B., Jaina, R. K., Bachhawat, B. K., & Gupta, C. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81760-w · Cited by 37 · see citing works

Rehydrated Lyophilized Rifampicin-Loaded mPEG–DSPE Formulations for Nebulization

Abdulla, J. M. A., Tan, Y. T.-F., & Darwis, Y. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9428-6 · Cited by 36 · see citing works

Tuftsin-Bearing Liposomes as Antibiotic Carriers in Treatment of Macrophage Infections

Gupta, C. M., & Haq, W. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91016-1 · Cited by 35 · see citing works

Therapeutic Efficacy of Liposome-encapsulated Kanamycin against Mycobacterium intracellulare Infection Induced in Mice

Tomioka, H., Saito, H., Sato, K., & Yoneyama, T. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.3_pt_1.575 · Cited by 35 · see citing works

Delivery of liposomes in dry powder form: aerodynamic dispersion properties

Desai, T. R., Hancock, R. E. W., & Finlay, W. H. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.09.008 · Cited by 35 · see citing works

Aerosol vaccines for tuberculosis: A fine line between protection and pathology

Hokey, D. A., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.09.007 · Cited by 35 · see citing works

Spray‐dried carrier‐free dry powder tobramycin formulations with improved dispersion properties

Pilcer, G., Vanderbist, F., & Amighi, K. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21545 · Cited by 33 · see citing works

Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with PulmonaryBurkholderia cepaciaInfection

Marier, J., Lavigne, J. R., & Ducharme, M. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3776-3781.2002 · Cited by 33 · see citing works

Inhaled Antimicrobial Therapy: From Cystic Fibrosis to the Flu

O’Riordan, T. G. (2000) · Respiratory Care · doi:10.1177/002013240004500707 · Cited by 30 · see citing works

Murine airway histology and intracellular uptake of inhaled amorphous itraconazole

Vaughn, J. M., Wiederhold, N. P., McConville, J. T., Coalson, J. J., Talbert, R. L., Burgess, D. S., Johnston, K. P., Williams, R. O., & Peters, J. I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.014 · Cited by 29 · see citing works

Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.

de Galan, B. E., Şimşek, S., Tack, C. J., & Heine, R. J. (2006) · PubMed · Cited by 28 · see citing works

Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model

Petersen, E. A., Grayson, J. B., Hersh, E. M., Dorr, R. T., Chiang, S.-M., Oka, M., & Proffitt, R. T. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.819 · Cited by 26 · see citing works

INHALED PENICILLIN IN BRONCHIAL INFECTIONS

Southwell, N. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91998-8 · Cited by 25 · see citing works

Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections

Mohammad, R. A., & Klein, K. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g477 · Cited by 25 · see citing works

Toxicological evaluation of lactose and chitosan delivered by inhalation

Valle, M. J. D. J., Dinis‐Oliveira, R. J., Carvalho, F. D., Bastos, M. D. L., & Navarro, A. S. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208783721038 · Cited by 22 · see citing works

Ribavirin small-particle-aerosol treatment of influenza B virus infection

Bernstein, D. I., Reuman, P. D., Sherwood, J. R., Young, E. C., & Schiff, G. M. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.761 · Cited by 22 · see citing works

Micelle-based Systems for Pulmonary Drug Delivery and Targeting

Andrade, F., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2011) · Drug Delivery Letters · doi:10.2174/2210303111101020171 · Cited by 22 · see citing works

In vitrocharacterization of nebulizer delivery of liposomal amphotericin B aerosols

Alexander, B. D., Winkler, T. P., Shi, S., Ashley, E. S. D., & Hickey, A. J. (2011) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2011.591803 · Cited by 19 · see citing works

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Jones, L. H., Baldock, H., Bunnage, M. E., Burrows, J. L., Clarke, N., Coghlan, M., Entwistle, D. A., Fairman, D., Feeder, N., Fulton, C. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.132 · Cited by 18 · see citing works

PENICILLIN INHALATION IN PULMONARY DISEASE

Humphrey, J., & Joules, H. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91997-6 · Cited by 17 · see citing works

Micelle-based Systems for Pulmonary Drug Delivery and Targeting

Andrade, F., Videira, M., Ferreira, D. C., et al. (2011) · Drug Delivery Letters · doi:10.2174/2210304x11101020171 · Cited by 16 · see citing works

Particulate and Vesicular Drug Carriers in the Management of Tuberculosis

Rastogi, R., Sultana, Y., Ali, A., & Aqil, M. (2005) · Current Drug Delivery · doi:10.2174/156720106775197448 · Cited by 15 · see citing works

Aerosol Penicillin in the Oxygen Tent

Knott, F. A., & Southwell, N. (1946) · Archives of Disease in Childhood · doi:10.1136/adc.21.105.16 · Cited by 10 · see citing works

Killer respiratory tract infections

Zumla, A. I. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328351f7d8 · Cited by 10 · see citing works

Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration

Crowder, T. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.579 · Cited by 3 · see citing works

Penicillin nebulization in bronchopulmonary disease; a preliminary report.

HURST, A. (1946) · PubMed · Cited by 2 · see citing works

The antimicrobial activity of nanoparticles: present situation and prospects for the future

Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062 · see citing works

New developments in liposomal drug delivery

Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600 · see citing works

Polymeric Nanoparticles for Drug Delivery

Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,229 · see citing works

Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”

Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 903 · see citing works

Nanostructured lipid carriers: Promising drug delivery systems for future clinics

Beloqui, A., Solinís, M. Á., Rodríguez‐Gascón, A., Almeida, A. J., & Véronique Préat, A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 790 · see citing works

Antibiotic‐Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives

Wang, Y., Yang, Y., Shi, Y., Song, H., & Yu, C. (2019) · Advanced Materials · doi:10.1002/adma.201904106 · Cited by 703 · see citing works

Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers

Sosnik, A., & Seremeta, K. P. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.05.003 · Cited by 679 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Polymeric Nanostructures for Imaging and Therapy

Elsabahy, M., Heo, G. S., Lim, S., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 507 · see citing works

Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review

Sosnik, A., das Neves, J., & Sarmento, B. F. C. C. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.07.010 · Cited by 489 · see citing works

Current applications of nanoparticles in infectious diseases

Gómez, H. Z., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 440 · see citing works

Therapeutic strategies to combat antibiotic resistance

Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 364 · see citing works

Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria

Yousefi, M., Dadashpour, M., Hejazi, M., Hasanzadeh, M., Behnam, B., de la Guárdia, M., Shadjou, N., & Mokhtarzadeh, A. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.12.125 · Cited by 258 · see citing works

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics

Mubeen, B., Ansar, A. N., Rasool, R., Ullah, I., Imam, S. S., Alshehri, S., Ghoneim, M. M., Alzarea, S. I., Nadeem, M. S., & Kazmi, I. A. (2021) · Antibiotics · doi:10.3390/antibiotics10121473 · Cited by 254 · see citing works

Inhaled formulations and pulmonary drug delivery systems for respiratory infections

Zhou, Q. T., Leung, S. S. Y., Tang, P., Parumasivam, T., Loh, Z. H., & Chan, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.022 · Cited by 248 · see citing works

Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery

Haripriyaa, M., & Suthindhiran, K. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00569-y · Cited by 189 · see citing works

Pulmonary drug delivery systems for tuberculosis treatment

Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185 · see citing works

Mesoporous silica nanoparticles for pulmonary drug delivery

García‐Fernández, A., Sancenón, F., & Martínez‐Máñez, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113953 · Cited by 183 · see citing works

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines

Guo, Y., Bera, H., Shi, C., Zhang, L., Cun, D., & Yang, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.015 · Cited by 172 · see citing works

Pulmonary drug delivery by powder aerosols

Yang, M., Chan, J. G. Y., & Chan, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.055 · Cited by 170 · see citing works

Polymeric micelles in mucosal drug delivery: challenges towards clinical translation

Sosnik, A., & Menaker Raskin, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.003 · Cited by 154 · see citing works

Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds

Ali, S. S., Morsy, R., El-Zawawy, N. A., Fareed, M. F., & Bedaiwy, M. Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141201 · Cited by 149 · see citing works

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy

Park, Y.-M., Lee, S. J., Kim, Y. S., Lee, M. H., Cha, G. S., Jung, I. D., Kang, T. H., & Han, H. D. (2013) · Immune Network · doi:10.4110/in.2013.13.5.177 · Cited by 135 · see citing works

Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products

Chang, X., Zhou, S., Yan, Z., Zhang, Q., Liu, J., Wang, Y., Guan, X., Wu, Q., & Liu, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.70008 · Cited by 134 · see citing works

Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance

Mehta, P. P., Ghoshal, D., Pawar, A., Kadam, S. S., & Dhapte-Pawar, V. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101509 · Cited by 128 · see citing works

The formulation of nanomedicines for treating tuberculosis

Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works

Medical applications and prospects of polylactic acid materials

Yang, Z., Yin, G., Sun, S., & Xu, P. (2024) · iScience · doi:10.1016/j.isci.2024.111512 · Cited by 123 · see citing works

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.038 · Cited by 119 · see citing works

Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations

Naskar, A., & Kim, K.-S. (2019) · Microorganisms · doi:10.3390/microorganisms7090356 · Cited by 118 · see citing works

Crosslinked-polyvinyl alcohol-carboxymethyl cellulose/ZnO nanocomposite fibrous mats containing erythromycin (PVA-CMC/ZnO-EM): Fabrication, characterization and in-vitro release and anti-bacterial properties

Darbasizadeh, B., Fatahi, Y., Feyzi-barnaji, B., Arabi, M., Motasadizadeh, H., Farhadnejad, H., Moraffah, F., & Rabiee, N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.060 · Cited by 112 · see citing works

Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections

Huang, Z., Kłodzińska, S. N., Wan, F., & Nielsen, H. M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00954-1 · Cited by 111 · see citing works

On-demand storage and release of antimicrobial peptides using Pandora's box-like nanotubes gated with a bacterial infection-responsive polymer

Chen, J., Shi, X., Zhu, Y., Chen, Y., Gao, M., Gao, H., Liu, L., Wang, L., Mao, C., & Wang, Y. (2019) · Theranostics · doi:10.7150/thno.38388 · Cited by 110 · see citing works

Development of a Multifunctional Platform Based on Strong, Intrinsically Photoluminescent and Antimicrobial Silica‐Poly(citrates)‐Based Hybrid Biodegradable Elastomers for Bone Regeneration

Du, Y., Yu, M., Ge, J., Ma, P. X., Chen, X., & Lei, B. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501712 · Cited by 95 · see citing works

The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review

Adeniji, O. O., Nontongana, N., Okoh, J. C., & Okoh, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315038 · Cited by 93 · see citing works

Photothermal-Induced Antibacterial Activity of Gold Nanorods Loaded into Polymeric Hydrogel against Pseudomonas aeruginosa Biofilm

Al‐Bakri, A. G., & Mahmoud, N. N. (2019) · Molecules · doi:10.3390/molecules24142661 · Cited by 90 · see citing works

Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery

Wang, H., Lu, Q., Zhang, X., Guan, J., & Mao, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.061 · Cited by 88 · see citing works

Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy

Moreno-Sastre, M., Pastor, M., Salomon, C. J., Esquisabel, A., & Pedraz, J. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv192 · Cited by 84 · see citing works

Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead

Velkov, T., Rahim, N. A., Zhou, Q. T., Chan, H., & Li, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.004 · Cited by 84 · see citing works

Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

Moreno-Sastre, M., Pastor, M., Esquisabel, A., Sans, E., Viñas, M., Fleischer, A., Palomino, E., Bachiller, D., & Pedraz, J. L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.028 · Cited by 84 · see citing works

Emerging delivery approaches for targeted pulmonary fibrosis treatment

Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 78 · see citing works

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers

Muralidharan, P., Mallory, E. K., Malapit, M., Hayes, D., & Mansour, H. M. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6020333 · Cited by 76 · see citing works

Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections

Araújo, V. H. S., Filippo, L. D. D., Duarte, J. L., Spósito, L., de Camargo, B. A. F., da Silva, P. B., & Chorilli, M. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843399 · Cited by 73 · see citing works

Molecular and cellular cues governing nanomaterial–mucosae interactions: from nanomedicine to nanotoxicology

das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 72 · see citing works

Cyclic Peptide–Selenium Nanoparticles as Drug Transporters

Shirazi, A. N., Tiwari, R. K., Oh, D., Sullivan, B., Kumar, A., Beni, Y. A., & Parang, K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500364a · Cited by 71 · see citing works

Nanoparticles: Antimicrobial Applications and Its Prospects

Varier, K. M., Gudeppu, M., Chinnasamy, A., Sumathi, T., Balasubramanian, J., Li, Y., & Gajendran, B. (2019) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-04477-0_12 · Cited by 69 · see citing works

Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis

Machelart, A., Salzano, G., Li, X., Demars, A. M., Debrie, A., Menéndez-Miranda, M., Pancani, E., Jouny, S., Hoffmann, E., Deboosère, N., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07902 · Cited by 69 · see citing works

Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis

Pastor, M., Moreno-Sastre, M., Esquisabel, A., Sans, E., Viñas, M., Bachiller, D., Asensio, V. J., del Pozo, Á., Gaínza, E., & Pedraz, J. L. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.048 · Cited by 68 · see citing works

How can nanoparticles contribute to antituberculosis therapy?

Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68 · see citing works

Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro–in vivo suitability as pulmonary delivery systems

Manca, M. L., Peris, J., Melis, V., Valenti, D., Cardia, M. C., Lattuada, D., Escribano‐Ferrer, E., Fadda, A. M., & Manconi, M. (2015) · RSC Advances · doi:10.1039/c5ra24032h · Cited by 67 · see citing works

Safety Assessment of Nanomaterials for Antimicrobial Applications

Ali, A. S., Ovais, M., Cui, X., Rui, Y., & Chen, C. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00519 · Cited by 65 · see citing works

Human immunity in vitro — Solving immunogenicity and more

Giese, C., & Marx, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.011 · Cited by 62 · see citing works

Metal-based nanoparticles for combating antibiotic resistance

Altun, E., Aydoğdu, M. O., Chung, E., Ren, G., Homer‐Vanniasinkam, S., & Edirisinghe, M. J. (2021) · Applied Physics Reviews · doi:10.1063/5.0060299 · Cited by 61 · see citing works

Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs

Melis, V., Manca, M. L., Bullita, E., Tamburini, E., Castangia, I., Cardia, M. C., Valenti, D., Fadda, A. M., Peris, J., & Manconi, M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.044 · Cited by 60 · see citing works

Extraction of essential oil from Dracocephalum kotschyi Boiss. (Lamiaceae), identification of two active compounds and evaluation of the antimicrobial properties

Ghavam, M., Manconi, M., Manca, M. L., & Bacchetta, G. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113513 · Cited by 60 · see citing works

Emerging aerosol drug delivery strategies: From bench to clinic

Rubin, B. K., & Williams, R. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.008 · Cited by 57 · see citing works

Nanomedicines in the future of pediatric therapy.

Sosnik, A., & Carcaboso, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.004 · Cited by 54 · see citing works

Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections

Sabuj, M. Z. R., & Islam, N. (2021) · Nanoscale Advances · doi:10.1039/d1na00205h · Cited by 56 · see citing works

Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin

Andrade, F., das Neves, J., Gener, P., Schwartz, S., Ferreira, D., Oliva, M., & Sarmento, B. F. C. C. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.006 · Cited by 55 · see citing works

Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders

Wan, T. Y., & Yuan, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.002 · Cited by 55 · see citing works

Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation

Song, X., Liu, P., Liu, X., Wang, Y., Wei, H., Zhang, J., Yu, L., Yan, X., & He, Z. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112318 · Cited by 55 · see citing works

A mechanistic perspective on targeting bacterial drug resistance with nanoparticles

Khorsandi, K., Keyvani‐Ghamsari, S., Shahidi, F. K., Hosseinzadeh, R., & Kanwal, S. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1895818 · Cited by 52 · see citing works

Formulation and evaluation of chitosan/polyethylene oxide nanofibers loaded with metronidazole for local infections

Zupančič, Š., Potrč, T., Baumgartner, S., Kocbek, P., & Kristl, J. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.030 · Cited by 52 · see citing works

Antibiotic resistance and nanotechnology: A narrative review

Zhu, X., Tang, Q., Zhou, X., & Momeni, M. R. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106741 · Cited by 50 · see citing works

Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

Li, J., Zhang, K., Wu, D., Ren, L., Chu, X., Qin, C., Han, X., Hang, T., Xu, Y., Yang, L., et al. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.09.002 · Cited by 48 · see citing works

Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives

Dawood, A. S., Algharib, S. A., Zhao, G., Zhu, T., Qi, M., Delai, K., Hao, Z., Marawan, M. A., Shirani, I., & Guo, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.855731 · Cited by 48 · see citing works

Biodegradation of the ZnO:Eu nanoparticles in the tissues of adult mouse after alimentary application

Kiełbik, P., Kaszewski, J., Rosowska, J., Wolska, E., Witkowski, B. S., Gralak, M. A., Gajewski, Z., Godlewski, M., & Godlewski, M. M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.002 · Cited by 48 · see citing works

Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines

Balasubramanian, V., Liu, Z., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700432 · Cited by 46 · see citing works

New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development

Igarashi, M., Ishizaki, Y., & Takahashi, Y. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.126 · Cited by 46 · see citing works

Alginate-pluronic topical gels loaded with thymol, norfloxacin and ZnO nanoparticles as potential wound dressings

Buyana, B., Aderibigbe, B. A., Ndinteh, D. T., Fonkui, T. Y., & Kumar, P. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101960 · Cited by 46 · see citing works

Solubility and Dissolution Enhancement of Tadalafil Using Self-Nanoemulsifying Drug Delivery System

El‐Badry, M., Haq, N., Fetih, G. N., & Shakeel, F. (2014) · Journal of Oleo Science · doi:10.5650/jos.ess13236 · Cited by 45 · see citing works

The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA

Xu, C., Tian, H., Wang, P., Wang, Y., & Chen, X. (2016) · Biomaterials Science · doi:10.1039/c6bm00601a · Cited by 45 · see citing works

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

Ibarra-Sánchez, L. Á., Gámez-Méndez, A. M., Martínez-Ruiz, M., Nájera-Martínez, E. F., Morales-Flores, B., Melchor-Martínez, E. M., Sosa‐Hernández, J. E., Parra‐Saldívar, R., & Iqbal, H. M. N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103219 · Cited by 45 · see citing works

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

Xu, K., Liang, Z. C., Ding, X., Hu, H., Liu, S., Nurmik, M., Bi, S., Hu, F.-S., Ji, Z., Ren, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700509 · Cited by 44 · see citing works

Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa

Yan, X., & Sha, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102457 · Cited by 43 · see citing works

Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment

Valle, I. V., Machado, M. E., Araújo, C. D. C. B., Cunha‐Júnior, E. F., Pacheco, J. D. S., Torres-Santos, E. C., da Silva, L. C. R. P., Cabral, L. M., do Carmo, F. A., & Sathler, P. C. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab373e · Cited by 43 · see citing works

Production of Drug-Loaded Polymeric Nanoparticles by Electrospraying Technology

Sosnik, A. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1887 · Cited by 42 · see citing works

Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment

Li, J., Zheng, H., & Leung, S. S. Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03379-8 · Cited by 41 · see citing works

Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin

Rafael, D. F. D. S., Martínez-Trucharte, F., Andrade, F., Seras‐Franzoso, J., García‐Aranda, N., Gener, P., Sayós, J., Arango, D., Abasolo, I., & Schwartz, S. (2017) · Chemical Engineering Journal · doi:10.1016/j.cej.2017.12.114 · Cited by 40 · see citing works

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

Rafael, D. F. D. S., Gener, P., Andrade, F., Seras‐Franzoso, J., Montero, S., Fernández, Y., Hidalgo, M. M., Arango, D., Sayós, J., Florindo, H. F., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461276 · Cited by 40 · see citing works

Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

van der Weide, H., Cossío, U., Gracia, R., Welscher, Y. M. T., ten Kate, M. T., van der Meijden, A., Marradi, M., Ritsema, J. A. S., Jongh, D. M. C. V.-D., Storm, G., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-20 · Cited by 40 · see citing works

A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery

Pasero, L., Susa, F., Limongi, T., & Pisano, R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124248 · Cited by 39 · see citing works

Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process

Farhangi, M. A., Mahboubi, A., Kobarfard, F., Vatanara, A., & Mortazavi, S. A. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1545237 · Cited by 39 · see citing works

Nanoparticle-Based Devices in the Control of Antibiotic Resistant Bacteria

Gómez-Núñez, M. F., Castillo-López, M., Sevilla-Castillo, F., Roque-Reyes, O. J., Romero-Lechuga, F., Medina-Santos, D., Daniel, R., & Peón, A. N. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.563821 · Cited by 39 · see citing works

Long-acting vaccine delivery systems

Walvekar, P., Kumar, P., & Choonara, Y. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114897 · Cited by 39 · see citing works

Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines

Beg, S., Kawish, S. M., Panda, S. K., Tarique, M., Malik, A., Afaq, S., AlSamghan, A. S., Iqbal, J., Alam, K., & Rahman, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.005 · Cited by 38 · see citing works

Solid state formulations composed by amphiphilic polymers for delivery of proteins: characterization and stability

Andrade, F., Fonte, P., Oliva, M., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.050 · Cited by 38 · see citing works

Nanopolymersomes as potential carriers for rifampicin pulmonary delivery

Moretton, M. A., Cagel, M., Bernabeu, E., González, L., & Chiappetta, D. A. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.049 · Cited by 36 · see citing works

A review of available techniques for determination of nano-antimicrobials activity

Hoseinzadeh, E., Makhdoumi, P., Taha, P., Hossini, H., Pirsaheb, M., Rastegar, S. O., & Stelling, J. M. (2016) · Toxin Reviews · doi:10.1080/15569543.2016.1237527 · Cited by 36 · see citing works

Synthesis of an oleic acid based pH-responsive lipid and its application in nanodelivery of vancomycin

Mhule, D., Kalhapure, R. S., Jadhav, M., Omolo, C. A., Rambharose, S., Mocktar, C., Singh, S. D., Waddad, A. Y., Ndesendo, V. M. K., & Govender, T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.025 · Cited by 36 · see citing works

Monodispersed metal-based dendrimeric nanoclusters for potentiation of anti-tuberculosis action

Rodrigues, B., & Shende, P. K. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.112731 · Cited by 36 · see citing works

Nanocarriers for tuberculosis therapy: Design of safe and effective drug delivery strategies to overcome the therapeutic challenges

Sarkar, K., Kumar, M., Jha, A., Bharti, K., Das, M., & Mishra, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102850 · Cited by 36 · see citing works

Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities

Nainwal, N. (2022) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2022.102170 · Cited by 36 · see citing works

Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements

Shastri, D., Raj, V., & Lee, S.-K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102379 · Cited by 34 · see citing works

Supercritical CO2-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation

Silva, M., Silva, A. S., Fernández‐Lodeiro, J., Casimiro, T., Lodeiro, C., & Aguiar‐Ricardo, A. (2017) · Materials · doi:10.3390/ma10010074 · Cited by 34 · see citing works

In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation

Patel, A., Redinger, N., Richter, A., Woods, A., Neumann, P., Keegan, G. M., Childerhouse, N., Imming, P., Schaible, U. E., Forbes, B., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.022 · Cited by 34 · see citing works

Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects

Gulati, N., Chellappan, D. K., MacLoughlin, R. J., Dua, K., & Dureja, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119969 · Cited by 34 · see citing works

Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies

Sued, O. G., Figueroa, M. I., & Cahn, P. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.016 · Cited by 32 · see citing works

The challenges and applications of nanotechnology against bacterial resistance

Lei, Z., & Karim, A. (2020) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12936 · Cited by 32 · see citing works

Recent Advances in Nanotechnology for the Management of Klebsiella pneumoniae–Related Infections

Barani, M., Fathizadeh, H., Arkaban, H., Kalantar-Neyestanaki, D., Akbarizadeh, M. R., Jalil, A. T., & Akhavan‐Sigari, R. (2022) · Biosensors · doi:10.3390/bios12121155 · Cited by 32 · see citing works

Improving the Solubility, Dissolution, and Bioavailability of Metronidazole via Cocrystallization with Ethyl Gallate

Li, J., Hao, X., Wang, C., Liu, H., Liu, L., He, X., & Sun, C. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040546 · Cited by 31 · see citing works

Nano vs Resistant Tuberculosis: Taking the Lung Route

Sharma, D., Pooja, P., Nirban, S., Ojha, S., Kumar, T., Jain, N., Mohamad, N., Kumar, P., & Pandey, M. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02708-3 · Cited by 3 · see citing works

Drug Delivery Systems for Respiratory Infections

Padhi, S., & Behera, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-4392-7_22 · Cited by 2 · see citing works

Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review

Sheng, G., Tian, N., Duan, H., Sun, Z., & Chu, H. (2022) · Acta Materia Medica · doi:10.15212/amm-2022-0019 · Cited by 20 · see citing works

Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy

Moreno-Sastre, M., Pastor, M., Salomon, C. J., Esquisabel, A., & Pedraz, J. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv192 · Cited by 84 · see citing works

Nanostructure-Based Pulmonary Drug Delivery Systems for Respiratory Infections

Kumar, V., Singh, H., Tarannum, S., Batheja, S., Gupta, U. D., & Goyal, A. K. (2024) · CRC Press eBooks · doi:10.1201/9781003130055-6